emotional premenstrual symptoms occurring on one or more of the five days before menstruation, appearing in the previous three menstrual cycles, and dissipating within four days after the start of menstruation or at least thirteen days before the next menstrual cycle.
Women of all ages are increasingly participating in society, leading to an increased stress burden and additional housework. In women with PMS, additional work and stress during menstruation can cause symptoms characteristic of the menopausal transition period. In this study, we analyzed the prevalence of PMS in women who were experiencing symptoms related to the menopausal transition period.
Materials and Methods
This study included 100 perimenopausal women who had visited a university hospital within 6 months from October 2013 to March 2014 and completed a questionnaire survey regarding premenstrual symptoms after providing informed consent. The questionnaire contained basic information about age, height, and weight, and multiple-choice questions regarding the ten ACOG diagnostic criteria for PMS. Additional questions included information pertaining to menstrual regularity (cycle regularity), the duration of menstruation (cycle duration), menstrual quantity (amount of flow), menstrual cycle, menstrual pain severity, analgesic use, and visits to an obstetrician/gynecologist. The questionnaires also included screening questions regarding PMDD and describing the presence of somatic premenstrual symptoms (breast tenderness, abdominal bloating, headache, and swelling of the extremities), emotional premenstrual symptoms (depression, angry outbursts, irritability, confusion, and anxiety), and quality of life. ACOG and APA guidelines recommend that patients be prospectively evaluated at least twice before PMS and PMDD can be diagnosed; however, due to practical limitations, an accurate diagnosis of these disorders was not possible at the time the survey was administered.
The results of this study were analyzed using SPSS software version 18.0 (SPSS Inc., Chicago, IL, USA).
Comparisons of the mean were performed using Student's t-tests, while comparisons of fractions were made using χ 2 te sts. A multiple response analysis was used for multiple responses. In all cases, P < 0.05 was considered to be statistically significant.
Results

General characteristics
The average age of the respondents was 47.92 ± 1.89 years (range, 43-53 years), the average height was 1.57 ± 0.52 m, the average body weight was 55.8 ± 7.8 kg, and the symptoms of PMS. In our study 'breast tenderness' was the most common (n = 56), followed by 'abdominal bloating'
and 'headache' (n = 36). Reports of 'depression' (n = 28) and 'hands and feet are swelling' (n = 12) were low in the patient cohort. For the 100 women who were selected for this study, the average number of individual symptoms was 2.84 ± 2.02. The most common symptoms associated with PMDD were reported to be 'angry outbursts' (n = 33), and other symptoms of 'anxiety' (n = 22) ( Table 2 , 3).
Duration of the symptoms of PMS and the impact on social activities
Symptoms of PMS persisted for 3.1 ± 3.0 days in the patients in this study; 13 women reported that PMS affected their social activities and daily life (Table 2C) . 
Comparative analysis of PMS and PMDD
Frequency and symptoms of PMS and PMDD
The ACOG has identified ten of the most common whereas it is estimated that 3-8% of women have PMDD according to APA guidelines. 8 In comparison, Park et al. 9, 10 reported that among 200 Korean women of childbearing age the prevalence of PMDD was ~8%.
The purpose of this study was to investigate the extent Drug treatment with oral contraceptive pills, prostaglandin inhibitors, and spironolactone has also been used, 2 although medication should not be a first-line treatment.
Women increasingly experience physical and mental stress as they enter the workplace and deal with social stressors.
Women who work have a higher prevalence of PMS compared to women who do not, and the incidence of PMS among middle-aged women compared to adolescents has not been determined. It is difficult to generalize to an entire population based on a small sample size. However, it is likely that symptoms of PMS in young women persist during the menopausal transition. Those women who experience PMS and PMDD often struggle with serious social and family issues. Future studies will require a large sample size and generalized criteria for PMS and PMDD to verify the results of this study.
In this study, the prevalence of PMS was similar in perimenopausal women compared to younger women, and PMS and PMDD were diagnosed in all of the subjects regardless of age. Continued education and outreach are required to provide an accurate perception of PMS, and the implementation of effective medical treatments to improve the quality of life for patients and maximize business efficiency will be helpful in the future.
